{"id":2410,"date":"2024-10-24T15:17:55","date_gmt":"2024-10-24T12:17:55","guid":{"rendered":"https:\/\/thesciencesupport.com\/?p=2410"},"modified":"2024-10-24T15:17:55","modified_gmt":"2024-10-24T12:17:55","slug":"chromatography-systems-in-mab-production","status":"publish","type":"post","link":"https:\/\/thesciencesupport.com\/en\/chromatography-systems-in-mab-production\/","title":{"rendered":"Overcoming Purification and Formulation Challenges in mAb Production with Chromatography Systems"},"content":{"rendered":"

The production of highly concentrated monoclonal antibodies (mAbs)<\/a>1<\/sup> is essential for therapeutic applications<\/a>2<\/sup>, but it presents several technical challenges, particularly in the purification and formulation stages. Maintaining product stability, minimizing aggregation, and achieving high yields are critical factors that can impact both the efficacy and cost-efficiency of mAb production.\u00a0Advanced chromatography systems, such as Cytiva\u2019s AKTA\u2122 chromatography systems<\/a>, provide robust solutions to streamline these processes.<\/p>\n

Challenges in Purification and Formulation of mAbs<\/h3>\n

Monoclonal antibodies are large, complex molecules that require precise handling during production. A few of the challenges that manufacturers face during their production are:<\/p>\n

    \n
  1. Maintaining Product Stability:<\/strong> mAbs are prone to degradation, aggregation, and denaturation when subjected to variations in pH, temperature, and other conditions during purification and formulation.<\/li>\n
  2. Minimizing Aggregation:<\/strong> Aggregation can negatively affect both the safety and efficacy of mAbs. This makes the development of formulations that maintain solubility at high concentrations a key priority.<\/li>\n
  3. Achieving High Yields:<\/strong> Ensuring high recovery of the purified product while removing impurities and maintaining a stable, functional antibody is crucial for cost-efficient production.<\/li>\n<\/ol>\n

    How Chromatography Supports mAb Purification<\/h3>\n

    Chromatography remains one of the most effective techniques for purifying monoclonal antibodies. It is widely used to isolate mAbs from complex mixtures, ensuring the removal of impurities while maintaining high purity levels. Cytiva\u2019s AKTA chromatography systems, powered by the intelligent and intuitive UNICORN\u2122 software<\/a>, offer key advantages in addressing these challenges:<\/p>\n